SCHEMBL21717826

SCHEMBL21717826

CC(C)(C)c1ccc(-c2ccc3c(c2)c2cccc4c5ccccc5n3c42)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSPO P30536 2/20 0.39
SERPINE1 P05121 2/20 0.37
KDM4E B2RXH2 2/20 0.36
MEN1 O00255 2/20 0.36
ALDH1A1 P00352 2/20 0.36
MAPT P10636 2/20 0.36
KMT2A Q03164 2/20 0.36
POLB P06746 1/20 0.36
HPGD P15428 1/20 0.36
HTT P42858 1/20 0.36
KIF11 P52732 4/20 0.36
HSD17B2 P37059 1/20 0.36
ALKBH5 Q6P6C2 1/20 0.36
FTO Q9C0B1 1/20 0.36
PPARG P37231 1/20 0.36
DHODH Q02127 1/20 0.35
ASIC1 P78348 1/20 0.35
LMNA P02545 1/20 0.35
DNM1 Q05193 1/20 0.35
ICMT O60725 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16621748 0.91 KIF11 (0.39) TSPOSERPINE1KDM4EMEN1ALDH1A1
SCHEMBL21717860 0.91 KIF11 (0.38) TSPOKDM4EMEN1ALDH1A1MAPT
SCHEMBL22679615 0.89 TNKS (0.36) SERPINE1KIF11HSD17B2PPARGLMNA
SCHEMBL15460060 0.88 RXRA (0.42) TSPOSERPINE1ALDH1A1MAPTKIF11
SCHEMBL15460148 0.88 RXRA (0.42) TSPOSERPINE1ALDH1A1MAPTKIF11
SCHEMBL20689987 0.87 KIF11 (0.45) KDM4EMEN1ALDH1A1MAPTKMT2A
SCHEMBL10153530 0.87 KDM4E (0.44) TSPOKDM4EMEN1ALDH1A1MAPT
SCHEMBL15460070 0.87 TSPO (0.41) TSPOSERPINE1ALDH1A1MAPTKIF11
SCHEMBL15460145 0.87 TSPO (0.41) TSPOSERPINE1ALDH1A1MAPTKIF11
SCHEMBL16621739 0.87 KDM4E (0.44) TSPOKDM4EMEN1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12029119-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-07-02 US disclosed
US-11723272-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-08-08 US disclosed
US-11723272-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-08-08 US disclosed
US-20210005826-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO., LTD. (JP) 2021-01-07 US disclosed
US-20210005825-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2021-01-07 US disclosed
US-20200365812-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2020-11-19 US disclosed
US-20200052225-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12029119-B2 Organic electroluminescence element and electronic device LEF1, L1CAM, ESR2 TSPO 1263/4885SERPINE1 4041/4885KDM4E 2210/4885
US-20200052225-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE LEF1, L1CAM, ESR2 TSPO 1263/4885SERPINE1 4041/4885KDM4E 2210/4885
US-20210005825-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE OR51E2, CD99, CTNND1 TSPO 1545/4885SERPINE1 4585/4885KDM4E 2086/4885
US-20210005826-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC APPARATUS EML4, EBPL, LEF1 TSPO 789/4885SERPINE1 4268/4885KDM4E 2270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.